BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...
Johnson & Johnson MedTech announced 1-year results from the DISRUPT BTK II postmarket study, demonstrating sustained safety ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果